logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10471045 B1

PDFFull Text
Date of Patent:
Nov. 12, 2019

Filed:

Jul. 22, 2018

Compounds and methods for the treatment of microbial infections

Applicant:

The University of Hong Kong, Hong Kong, HK;

Inventors:

Yi Tsun Richard Kao, Hong Kong, HK;

Peng Gao, Hong Kong, HK;

Xuechen Li, Hong Kong, HK;

Ming Liu, Hong Kong, HK;

Assignee:

The University of Hong Kong, Hong Kong, HK;

Attorneys:

Idea Intellectual Limited

Margaret A. Burke

Sam T. Yip

Primary Examiner:

Po-Chih Chen

Int. Cl.
CPC ...
A61K 31/40 (2006.01); A61K 31/357 (2006.01); A61P 31/04 (2006.01); A61K 31/167 (2006.01); A61K 31/18 (2006.01); A61K 31/404 (2006.01); A61K 31/4402 (2006.01); A61K 31/4406 (2006.01); A61K 31/444 (2006.01); A61K 31/4453 (2006.01); A61K 31/454 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); C07D 317/60 (2006.01); C07D 295/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/40 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/357 (2013.01); A61K 31/404 (2013.01); A61K 31/4402 (2013.01); A61K 31/444 (2013.01); A61K 31/4406 (2013.01); A61K 31/4453 (2013.01); A61K 31/454 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61P 31/04 (2018.01); C07D 295/26 (2013.01); C07D 317/60 (2013.01);
Abstract

Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (I): The present methods include administering to a subject an effective amount of one or more compounds of Formula (I). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.

Find Patent Forward Citations

Loading…